Exclusive South-East Asia (SG) Investor Launch
SINGAPORE, Sept. 12, 2023 /PRNewswire/ -- Korean award-winning food-tech startup, HN Novatech is proud to launch ACOMS: the world's first proprietary heme-based seaweed ingredient for plant-based meat applications. On the 16th of August 2023, a group of leading south-east asian investors were treated to an exclusive and first taste test of HN Novatech's signature ingredient in, during Novatech's exclusive S.E.A launch in Singapore jointly organised by Singapore Tembusutech Innovation and KILSA Global.
HN Novatech is an award winning food materials technology company in South Korea with 19 patents filed under its belt to date. The company specialises in developing sustainable & cutting edge food ingredient alternatives, while maintaining a strong drive for culinary & palate excellence in their ingredient applications.
ACOMS, the name of the X-factor protein found and extracted from Seaweed, when applied to plant based meat primers, is what gives it it's "accurate meat" flavour. At the same time, HN Novatech's protein extraction process and final product rendering is additive and preservatives free — causing it to truly stand out in a plant-based world full of artificial additives, chemical and flavour enhancers.
Sean Tan (Co-founder KILSA Global), opines that the historical presence of seaweed in Asian diets spans centuries. As part of HN Novatech's exclusive Global management office team in Singapore, it's thrilling to observe how these oceanic veggies can be integrated into meat alternatives. The enthusiastic response and engagements from the event underline a dedicated move toward a more sustainable future.
$4m in venture funding secured despite extremely tough funding environment
HN Novatech has recently secured $4m in funding in its Series-A bridge round with Logan Ventures as its lead investor. Founding partner of Logan Ventures, remarked "We are excited to partner with Novatech, a leading AgTech startup in Asia, to offer natural meat alternatives which are delicious and healthy to meet a rising global demand."
Notably, HN Novatech's fundraise has occured in an environment which has witnessed the steepest fall in global venture funding, where in the first half of 2023, startup funding fell by 48% where many companies have struggled to raise capital throughout the year.
During this time, HN Novatech's CEO, Kim Yang-hee has hailed its successful capital raise as true testament to the growth of Novatech's advancing food technological capabilities and strong customer acquisition prospects for the months ahead. Additionally, Fortune Business Insider has remarked that the global meat substitutes market size was valued at USD 5.41 billion in 2021 and is projected to grow to USD 12.30 billion by 2029.
CEO, Kim Yang-hee with her team in Singapore
5 Year Global Expansion plans beginning with Asia
In recent times, the company has begun its venture into Asia Pacific regions with an eventual target of establishing itself as a globally acclaimed novel food materials leader, with a construction of a food technology processing facility beginning first in Korea. HN Novatech has also developed extremely strong R&D Capabilities having assembled a world class team of biotech engineers, food scientists, nutritionists and experienced professionals in business and sustainability enabling them to tackle complex problems and face challenges up ahead.
CEO Kim Yang-Hee remarked that the alternative meat industry's surge in the US and Europe is mirrored in Asia, where Singapore's appeal to multinational companies is bolstered by its strategic location, skilled workforce, and government support. HN Novatech is seizing this momentum by establishing a presence in Singapore, positioning itself as a key player in the growing plant-based meat substitute market within the ASEAN region.
